News Update
Endorsed by Shanghai Institute for Advanced Studies,CAS(SIAS-CAS)and organized by Shanghai Advanced Research Institute, CAS(SARI-CAS), Translational Systems Medicine Mini-Seminar was held in SIAS and SARI from May. 7th to 8th. Prof. Leroy Hood, President and co-founder of the Institute for Systems Biology and Member of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine of the United States; Prof.Robert Diasio, Director of Mayo Clinic Cancer Center; Prof.Thomas Brown, Chief Operating Officer of University of Arizona Cancer Center; Prof.Jing Cheng, Academician of Chinese Academy of Engineering and President of Tsinghua University School of Medicine; Prof. Qimin Zhan, Vice President of Chinese Academy of Medical Sciences and Director of the National Laboratory of Molecular Oncology and Prof. Biao Jiang, Vice President of SARI attended this seminar and delivered their speeches respectively. Leaders and experts from Fred Hutchinson Cancer Research Center, Shanghai Jiaotong University, Sun Yat-sen University and Chinese National Compound Library also joined the seminar.
On behalf of SARI, Prof.Biao Jiang extended warm welcome to all participants. He pointed out that translational systems medicine has become a heated topic all over the world. It is hoped that this seminar could serve as a good platform for all attendees to strengthen understanding and communication, making contributions to the development of medicine and health of human being.
Prof. JIANG was delivering a speech
Prof. Leroy Hood delivered a speech titled "A Translational Medicine Institute Should Practice Proactive P4 Medicine", in which he illustrated "P4" mode, naming predictive, preventive, personalized and participatory. He put forward his insight about how to practice P4 medicine and pointed out that P4 Medicine would have revolutionary influence on medicine development.
Prof. Leroy was delivering a speech
Prof. Edward Lin and Prof. Qiang Tian, Deans of the under-constructing Center for translational systems medicine of SARI introduced the blueprint, necessity and feasibility of the Center. They hoped that the Center could make contributions to the development of translational systems medicine by absorbing talents and forging cooperation with world-renowned institutions from both home and abroad.
Group photo
Prof.Robert Diasio, Prof.Jing Cheng, Prof.Qimin Zhan, etc. have made introductions of their respective institutes and exchanged their views on the development of translational systems medicine. Fruitful results and consensus on translational systems medicine have been made after heated discussion.